To reveal the relationship between p65 and AKT, GBM cells were treated with LGMN in the presence or absence of the NF-κB p65 pathway inhibitor SC75741 or the PI3K/AKT pathway inhibitor LY294002. This evidence concerns the gene NFKB1 and glioblastoma.